Web• Strong CYP3A4 Inhibitors: Use is contraindicated. (7.1) • Grapefruit or grapefruit juice: Avoid concomitant use. (7.1) • Moderate or weak CYP3A4 Inhibitors : Monitor serum potassium during drug initiation or dosage adjustment of either Kerendia or the moderate or weak CYP3A4 inhibitor, and adjust Keren dia dosage as appropriate (7.1) WebAug 13, 2024 · Kerendia (finerenone) is a prescription drug that’s used to reduce certain risks in adults who have chronic kidney disease (CKD) and type 2 diabetes. The drug comes as an oral tablet. It’s ...
Bayer
WebApr 30, 2024 · Farxiga Farxiga (dapagliflozin) is a first-in-class, oral, once-daily SGLT2 inhibitor. The research for Farxiga is advancing from cardiorenal effects to prevention and organ protection as science continues to identify the underlying links between the heart, kidneys and pancreas. Damage to one of these organs can cause the other organs to fail ... WebJul 23, 2024 · In July 2024, the FDA approved Bayer’s Kerendia (finerenone) to treat chronic kidney disease (CKD) in people with type 2 diabetes. Kerendia is the first … how to not sweat so much
US FDA approves FARXIGA™ tablets for the treatment of ... - AstraZeneca
WebHypotension (low blood pressure) Hyponatremia. In rare instances, Kerendia can cause more serious side effects. These can include: Hyperkalemia – patients with decreased kidney function and higher baseline blood potassium levels are at increased risk, monitor serum potassium levels, and adjust the dose as needed. Webinhibitors that are indicated to reduce the risk of kidney disease: Farxiga (dapagliflozin) and the Invokana (canagliflozin) family (Invokana, Invokamet, and Invokamet XR). While an official recommendation for Kerendia is not evident, we recognize the longer time in therapy these SGLT-2 inhibitors have. WebOct 19, 2024 · Finerenone (Kerendia) disrupts molecular activity believed to cause inflammation and tissue scarring in diabetic nephropathy. Research has shown that the drug may reduce the risk of kidney function decline, kidney failure, cardiovascular death, nonfatal heart attacks and hospitalization for heart failure in adults with chronic kidney disease ... how to not sweat through a dress